Regenxbio Inc’s recently made public that its Director Mills Kenneth T. unloaded Company’s shares for reported $0.16 million on May 12 ’25. In the deal valued at $7.91 per share,20,602 shares were sold. As a result of this transaction, Mills Kenneth T. now holds 475,103 shares worth roughly $4.07 million.
Then, KENNETH MILLS bought 20,602 shares, generating $154,927 in total proceeds.
Before that, VITTAL VASISTA bought 20,041 shares. Regenxbio Inc shares valued at $148,504 were divested by the Officer at a price of $7.41 per share.
Goldman downgraded its Regenxbio Inc [RGNX] rating to a Neutral from a a Buy in a research note published on February 11, 2025; the price target was decreased to $14 from $38.
Price Performance Review of RGNX
On Tuesday, Regenxbio Inc [NASDAQ:RGNX] saw its stock jump 0.94% to $8.57. Over the last five days, the stock has gained 4.00%. Regenxbio Inc shares have fallen nearly -33.31% since the year began. Nevertheless, the stocks have risen 10.87% over the past one year. While a 52-week high of $15.36 was reached on 06/02/25, a 52-week low of $5.03 was recorded on 04/09/25.
Levels Of Support And Resistance For RGNX Stock
The 24-hour chart illustrates a support level at 8.38, which if violated will result in even more drops to 8.18. On the upside, there is a resistance level at 8.73. A further resistance level may holdings at 8.88.
How much short interest is there in Regenxbio Inc?
A steep rise in short interest was recorded in Regenxbio Inc stocks on 2025-06-13, dropping by -0.79 million shares to a total of 5.51 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 6.3 million shares. There was a decline of -14.35%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 07, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $38 price target.
